Acknowledging the kind of traction gained by this market, Industry data Analytics recently published a study report asserts the global Vaccine Adjuvants Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 12.6% during the review period (2022 to 2027).
The market is experiencing growth due to rising awareness regarding various medical applications such as pain management, appetite enhancement, and reducing eye pressure.Vaccine Adjuvants is mainly classified into two types, namely Cannabis Sativa and Cannabis indica, which originate from the countries of the Western hemisphere and Central and South Asian regions respectively. The growing number of countries legalizing the use of Vaccine Adjuvants in various parts of this world is one of the key factors driving the usage rate of cannabis in therapeutic applications.
Based on application, the pain management segment is expected to dominate this market, owing to increasing incidence of pain related conditions, such as migraine, cancer pain and others. For instance, in previous year, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20%, have some form of chronic pain. People suffering from chronic pain tend to adopt high dosage of painkiller for instant relief. Though, growing intake of painkillers may result in multiple side effects. Hence, the medical community initiated the usage of cannabis as an alternative for pain management, thereby augmenting the market growth.
Industry Developments:
August 2 2021: Agenus (NASDAQ: AGEN), an immuno-oncology company with a wide range of antibodies, cell treatments, supplements, and vaccines designed to convert antibodies to cancer and infection.
August 7, 2021: Shares of biotech company Novavax NVAX plummeted to 19.6% on Friday trading after delays in US delivery of its third Covid-19 vaccine. Novavax said it now expects to apply for an authorization for emergency use in the U.S. In the fourth quarter of this year.
The Vaccine Adjuvants Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market includes Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France) and others.
Vaccine Adjuvants Market is segmented based on the type, applications, companies and regions.
By Product Type, it is segmented into
By Route of Administration
By Application it is segmented into
Route of Application Category
North America dominates the vaccine adjuvants market owing to the well-established veterinary healthcare infrastructure. Asia-Pacific is anticipated to score maximum growth rate and exhibit the highest CAGR for the forecast period 2022-2027. This is because of the rising expenditure to develop veterinary healthcare infrastructure and increased focus of the government towards immunization programs. In addition, according to the National Clinical Trials (NCT) Registry, as of September 21, 2020, in the United States, nearly 500 vaccine clinical trials are under development, which are anticipated to have an optimistic impact on the study market for these services. They are effective in increasing or activating the immune system. Therefore, ongoing clinical trials related to vaccine development and high-quality research activities in the United States are anticipated to further the market growth studied in North America in the forecast period.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 12.6% during the review period (2022 to 2027). |
By Type | By Product Type, it is segmented into
By Route of Administration
|
By Application | By Application it is segmented into
Route of Application Category
|
By Companies | Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France). |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 113 |
Customization Available | Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The Vaccine Adjuvants Market is studied from 2017 - 2027.
What is the growth rate of Vaccine Adjuvants Market?
The Vaccine Adjuvants Market is growing at a CAGR of 12.6% over the next 5 years.
Who are the leading key players in Vaccine Adjuvants Market?
Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).
What regions regions does this Vaccine Adjuvants Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Vaccine Adjuvants Market?
Pathogen, Adjuvant Emulsion, Particulate, Combination, Others
What are the significant Applications of Vaccine Adjuvants Market?
Infectious Diseases, Cancer, Others
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.